These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

534 related items for PubMed ID: 27693991

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F, Mazzucco E, Gennaro MC, Marengo E.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May 15; 927():22-36. PubMed ID: 23317577
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Expanding analytical possibilities concerning the detection of stanozolol misuse by means of high resolution/high accuracy mass spectrometric detection of stanozolol glucuronides in human sports drug testing.
    Schänzer W, Guddat S, Thomas A, Opfermann G, Geyer H, Thevis M.
    Drug Test Anal; 2013 May 15; 5(11-12):810-8. PubMed ID: 23873860
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Detection of prohibited substances by liquid chromatography tandem mass spectrometry for sports doping control.
    Ahrens BD, Starcevic B, Butch AW.
    Methods Mol Biol; 2012 May 15; 902():115-28. PubMed ID: 22767112
    [Abstract] [Full Text] [Related]

  • 10. Non-targeted acquisition strategy for screening doping compounds based on GC-EI-hybrid quadrupole-Orbitrap mass spectrometry: A focus on exogenous anabolic steroids.
    de Albuquerque Cavalcanti G, Rodrigues LM, Dos Santos L, Zheng X, Gujar A, Cole J, Padilha MC, de Aquino Neto FR.
    Drug Test Anal; 2018 Mar 15; 10(3):507-517. PubMed ID: 28600878
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mass spectrometric characterization of a prolyl hydroxylase inhibitor GSK1278863, its bishydroxylated metabolite, and its implementation into routine doping controls.
    Thevis M, Milosovich S, Licea-Perez H, Knecht D, Cavalier T, Schänzer W.
    Drug Test Anal; 2016 Aug 15; 8(8):858-63. PubMed ID: 26361079
    [Abstract] [Full Text] [Related]

  • 13. Liquid chromatography-high resolution/ high accuracy (tandem) mass spectrometry-based identification of in vivo generated metabolites of the selective androgen receptor modulator ACP-105 for doping control purposes.
    Thevis M, Thomas A, Piper T, Krug O, Delahaut P, Schänzer W.
    Eur J Mass Spectrom (Chichester); 2014 Aug 15; 20(1):73-83. PubMed ID: 24881457
    [Abstract] [Full Text] [Related]

  • 14. Determination of prohibited, small peptides in urine for sports drug testing by means of nano-liquid chromatography/benchtop quadrupole orbitrap tandem-mass spectrometry.
    Thomas A, Walpurgis K, Krug O, Schänzer W, Thevis M.
    J Chromatogr A; 2012 Oct 12; 1259():251-7. PubMed ID: 22901302
    [Abstract] [Full Text] [Related]

  • 15. Generic sample preparation combined with high-resolution liquid chromatography-time-of-flight mass spectrometry for unification of urine screening in doping-control laboratories.
    Peters RJ, Oosterink JE, Stolker AA, Georgakopoulos C, Nielen MW.
    Anal Bioanal Chem; 2010 Apr 12; 396(7):2583-98. PubMed ID: 20155493
    [Abstract] [Full Text] [Related]

  • 16. Fast analysis of doping agents in urine by ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry I. Screening analysis.
    Badoud F, Grata E, Perrenoud L, Avois L, Saugy M, Rudaz S, Veuthey JL.
    J Chromatogr A; 2009 May 15; 1216(20):4423-33. PubMed ID: 19342059
    [Abstract] [Full Text] [Related]

  • 17. Development of liquid chromatography-tandem mass spectrometry-based analytical assays for the determination of HIF stabilizers in preventive doping research.
    Beuck S, Bornatsch W, Lagojda A, Schänzer W, Thevis M.
    Drug Test Anal; 2011 May 15; 3(11-12):756-70. PubMed ID: 22213684
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.